Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 18,576–18,600 of 27,380 studies, newest first · page 744 of 1096.

July 2013 20

  1. 2013-07-01

    Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force

    ✓ Peer-reviewed Treatments Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: An international task force of investigators from academia, industry, nonprofit foundations, and regulatory agencies met in Monte Carlo, Monaco, on October 31, 2012, to review lessons learned from the recent bapineuzumab and solanezumab trials, and to incorporate insights gained from these trials into future clinical studies. +3 more findings

  2. 2013-07-01

    Brain health and exercise in older adults

    ✓ Peer-reviewed Prevention trials Current sports medicine reports

    Key finding: Evidence suggests that exercise and cognitive training benefit cognitive health in older adults; however, a preferred modality has to be endorsed yet by the scientific community. +1 more finding

  3. 2013-07-01

    Mediterranean diet and cognitive function in older age

    ✓ Peer-reviewed Prevention trials Epidemiology (Cambridge, Mass.)

    Key finding: In this large study of older women, we observed no association of the Mediterranean diet with cognitive decline. +3 more findings

  4. 2013-07-01

    Psychosis in Children and Youth: Focus on Early-Onset Schizophrenia

    ✓ Peer-reviewed Risk factors Pediatrics in Review

    Key finding: In the history of psychiatry, the words mad and psychosis have often been used interchangeably, negatively contributing to the stigma associated with the term and the illness itself. +4 more findings

  5. 2013-07-01

    O4–04–05: Geographical variation in dementia prevalence in Swedish twins: Using Bayesian inference to separate genetic and environmental effects

    ✓ Peer-reviewed Risk factors Alzheimer s & Dementia

    Key finding: The smoothed area odds ratio of dementia, after adjusting for age and twin random effects, showed a marked south-north gradient, with increased risk in the north in both men and women (See Figure.).

  6. 2013-07-01

    O4–04–02: Prevalence studies of dementia in mainland China, Hong Kong and Taiwan: A systematic review and meta‐analysis

    ✓ Peer-reviewed Risk factors Alzheimer s & Dementia

    Key finding: However, the influence of methodological factors on the results is seldom considered in these reviews and area prevalence has not been estimated adjusting comprehensively for various research methods between the studies. +3 more findings

  7. 2013-07-01

    PC‐009: Integrated medical and case management dementia model

    ✓ Peer-reviewed Health systems and care delivery Alzheimer s & Dementia

    Key finding: With almost twenty percent of the population in western North Carolina over age 65 compared to thirteen percent in the rest of the state and country, the need for such a program came sooner than in many communities.

  8. 2013-07-01

    Effects of anesthetic isoflurane and desflurane on human cerebrospinal fluid Aβ and τ level

    ✓ Peer-reviewed Tau biomarkers Anesthesiology

    Key finding: Accumulation of β-amyloid protein (Aβ) and tau protein is the main feature of Alzheimer disease neuropathogenesis. +3 more findings

  9. 2013-07-01

    The importance of tau phosphorylation for neurodegenerative diseases

    ✓ Peer-reviewed Lewy body dementia Frontiers in neurology

    Key finding: Increasing evidence suggests that the presence of these end-stage neurofibrillary lesions do not cause neuronal loss, but rather that alterations to soluble tau proteins induce neurodegeneration. +1 more finding

  10. 2013-07-01
  11. 2013-07-01

    Sleep Fragmentation and the Risk of Incident Alzheimer's Disease and Cognitive Decline in Older Persons

    ✓ Peer-reviewed How common it is Sleep

    Key finding: Sleep fragmentation in older adults is associated with incident AD and the rate of cognitive decline. +4 more findings

  12. 2013-07-01

    Improving access to dementia services for people from minority ethnic groups

    ✓ Peer-reviewed Disparities Current opinion in psychiatry

    Key finding: Only a minority of people with dementia receive a formal diagnosis despite a growing body of evidence highlighting the benefits of early diagnosis and intervention.

  13. 2013-07-01

    Caregiver health: health of caregivers of Alzheimer's and other dementia patients

    ✓ Peer-reviewed Caregiving Current psychiatry reports

    Key finding: Alzheimer's disease (AD) is the most common type of dementia and is a significant public health problem that will intensify as the population ages. +2 more findings

  14. 2013-07-01

    Imaging markers for Alzheimer disease: which vs how

    ✓ Peer-reviewed Brain scans and imaging Neurology

    Key finding: Markers accounted for 11% and 18% of diagnostic and prognostic variance of LR+ and 16% and 24% of LR-. +4 more findings

  15. 2013-07-01

    Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus

    ✓ Peer-reviewed Getting a diagnosis JAMA internal medicine

    Key finding: During the 12-year follow-up period, 61 participants (7.8%) had a reported hypoglycemic event, and 148 (18.9%) developed dementia. +2 more findings

  16. 2013-07-01

    Is there evidence for cognitive intervention in Alzheimer disease? A systematic review of efficacy, feasibility, and cost-effectiveness

    ✓ Peer-reviewed Treatments Alzheimer disease and associated disorders

    Key finding: Several studies have shown that cognitive intervention may be beneficial for people with Alzheimer disease (AD), but literature reviews conducted so far, have yielded mixed and inconclusive results. +2 more findings

  17. 2013-07-01
  18. 2013-07-01

    Mediterranean diet, cognitive function, and dementia: a systematic review

    ✓ Peer-reviewed Treatments Epidemiology (Cambridge, Mass.)

    Key finding: Published studies suggest that greater adherence to Mediterranean diet is associated with slower cognitive decline and lower risk of developing Alzheimer disease. +3 more findings

  19. 2013-07-01

    APOE-ε2 and APOE-ε4 correlate with increased amyloid accumulation in cerebral vasculature

    ✓ Peer-reviewed Genetics Journal of neuropathology and experimental neurology

    Key finding: The APOE-ε4 allele correlates with increased risk of Alzheimer disease (AD) and increased parenchymal amyloid plaques. +2 more findings

  20. 2013-07-01

    Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. Amyloid Imaging Task Force of the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Amyloid PET imaging is a novel diagnostic test that can detect in living humans one of the two defining pathologic lesions of Alzheimer disease, amyloid-β deposition in the brain. +2 more findings

June 2013 5

  1. 2013-06-30

    CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation

    ✓ Peer-reviewed Risk factors Nature immunology

    Key finding: Collectively, our findings highlight the importance of CD36 in the accrual and nucleation of NLRP3 ligands from within the macrophage and position CD36 as a central regulator of inflammasome activation in sterile inflammation.

  2. 2013-06-29

    Recent advances in the application of metabolomics to Alzheimer's Disease

    ✓ Peer-reviewed Treatments Biochimica et biophysica acta

    Key finding: The pathophysiological changes associated with Alzheimer's Disease (AD) begin decades before the emergence of clinical symptoms. +1 more finding

  3. 2013-06-29

    CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer's disease

    ✓ Peer-reviewed Long-term cohort studies Acta neuropathologica

    Key finding: In addition, AD and LBD are often found in the same patients at autopsy; therefore, biomarkers that can detect the presence of both pathologies in living subjects are needed. +3 more findings

  4. 2013-06-29

    Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI

    ✓ Peer-reviewed Long-term cohort studies Acta neuropathologica

    Key finding: To clarify this issue, we analyzed the longitudinal CSF tau and Aβ biomarker data from 142 of the AD Neuroimaging Initiative (ADNI) study subjects [18 AD, 74 mild cognitive impairment (MCI), and 50 cognitively normal subjects (CN)]. +3 more findings

  5. 2013-06-28

    Mood and memory deficits in a model of Gulf War illness are linked with reduced neurogenesis, partial neuron loss, and mild inflammation in the hippocampus

    ✓ Peer-reviewed Hippocampus size on brain scans Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

    Key finding: Furthermore, these behavioral impairments were associated with reduced hippocampal volume and multiple cellular alterations such as chronic reductions in neural stem cell activity and neurogenesis, partial loss of principal neurons, and mild inflammation comprising sporadic occurrence of activated microglia and significant hypertrophy of astrocytes. +1 more finding

Browse the library by subject, with the full score breakdown →